FDA requires doctors, manufacturers to disclose breast implant risks to prospective patients – The Washington Post

One part of new FDA rules restricts the sale and distribution of breast implants to providers and facilities that provide patients with a checklist of risks published by the FDA essentially mandating… [+4496 chars]

View The Article On: The Washington Post

Powered By

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

To Top